KLK6 and Cognitive impairment: In a cross-sectional study, Patra and colleagues [24] did neither find group differences of CSF-KLK6 between subjective cognitive impairment (n = 43) and AD (n = 43), nor between clinically diagnosed normal controls (n = 58) and clinically diagnosed progressive MCI n = 28).